Search Orphan Drug Designations and Approvals
-
Generic Name: | sugemalimab |
---|---|
Date Designated: | 10/08/2020 |
Orphan Designation: | treatment of T-cell lymphoma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
CStone Pharmaceuticals (Suzhou) Co., Ltd. 399 West Haiyang Road, New Bund Times Square, 21/F Shanghai 200126 China The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-